183 related articles for article (PubMed ID: 29486699)
1. Mitochondria-Targeted Antioxidant SkQ1 (10-(6´-Plastoquinonyl)decyltriphenylphosphonium Bromide) Inhibits Mast Cell Degranulation in vivo and in vitro.
Chelombitko MA; Averina OA; Vasilyeva TV; Pletiushkina OY; Popova EN; Fedorov AV; Chernyak BV; Shishkina VS; Ilinskaya OP
Biochemistry (Mosc); 2017 Dec; 82(12):1493-1503. PubMed ID: 29486699
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Effects of Mitochondria-Targeted Antioxidant 10-(6'-Plastoquinonyl)Decyltriphenylphosphonium Bromide (SkQ1) and a Fragment of its Molecule Dodecyltriphenylphosphonium on Carrageenan-Induced Acute Inflammation in Mouse Model of Subcuteneous Air Pouch.
Chelombitko MA; Averina OA; Vasil'eva TV; Dvorianinova EE; Egorov MV; Pletjushkina OY; Popova EN; Fedorov AV; Romashchenko VP; Ilyinskaya OP
Bull Exp Biol Med; 2017 Apr; 162(6):730-733. PubMed ID: 28429222
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted triphenylphosphonium-based compounds inhibit FcεRI-dependent degranulation of mast cells by preventing mitochondrial dysfunction through Erk1/2.
Pavlyuchenkova AN; Zinovkin RA; Makievskaya CI; Galkin II; Chelombitko MA
Life Sci; 2022 Jan; 288():120174. PubMed ID: 34826439
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.
Agapova LS; Chernyak BV; Domnina LV; Dugina VB; Efimenko AY; Fetisova EK; Ivanova OY; Kalinina NI; Khromova NV; Kopnin BP; Kopnin PB; Korotetskaya MV; Lichinitser MR; Lukashev AL; Pletjushkina OY; Popova EN; Skulachev MV; Shagieva GS; Stepanova EV; Titova EV; Tkachuk VA; Vasiliev JM; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1300-16. PubMed ID: 19120016
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice.
Demyanenko IA; Popova EN; Zakharova VV; Ilyinskaya OP; Vasilieva TV; Romashchenko VP; Fedorov AV; Manskikh VN; Skulachev MV; Zinovkin RA; Pletjushkina OY; Skulachev VP; Chernyak BV
Aging (Albany NY); 2015 Jul; 7(7):475-85. PubMed ID: 26187706
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1.
Shipounova IN; Svinareva DA; Petrova TV; Lyamzaev KG; Chernyak BV; Drize NI; Skulachev VP
Mech Ageing Dev; 2010 Jun; 131(6):415-21. PubMed ID: 20600239
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke).
Bakeeva LE; Barskov IV; Egorov MV; Isaev NK; Kapelko VI; Kazachenko AV; Kirpatovsky VI; Kozlovsky SV; Lakomkin VL; Levina SB; Pisarenko OI; Plotnikov EY; Saprunova VB; Serebryakova LI; Skulachev MV; Stelmashook EV; Studneva IM; Tskitishvili OV; Vasilyeva AK; Victorov IV; Zorov DB; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1288-99. PubMed ID: 19120015
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice.
Demyanenko IA; Zakharova VV; Ilyinskaya OP; Vasilieva TV; Fedorov AV; Manskikh VN; Zinovkin RA; Pletjushkina OY; Chernyak BV; Skulachev VP; Popova EN
Oxid Med Cell Longev; 2017; 2017():6408278. PubMed ID: 28761623
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.
Stefanova NA; Ershov NI; Kolosova NG
Oxid Med Cell Longev; 2019; 2019():3984906. PubMed ID: 31396299
[TBL] [Abstract][Full Text] [Related]
10. Effect of SkQ1 on Activity of the Glutathione System and NADPH-Generating Enzymes in an Experimental Model of Hyperglycemia.
Voronkova YG; Popova TN; Agarkov AA; Zinovkin RA
Biochemistry (Mosc); 2015 Dec; 80(12):1614-21. PubMed ID: 26638687
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
Neroev VV; Archipova MM; Bakeeva LE; Fursova AZh; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZhN; Katargina LA; Khoroshilova-Maslova IP; Kilina OV; Kolosova NG; Kopenkin EP; Korshunov SS; Kovaleva NA; Novikova YP; Philippov PP; Pilipenko DI; Robustova OV; Saprunova VB; Senin II; Skulachev MV; Sotnikova LF; Stefanova NA; Tikhomirova NK; Tsapenko IV; Shchipanova AI; Zinovkin RA; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1317-28. PubMed ID: 19120017
[TBL] [Abstract][Full Text] [Related]
12. In vivo immunoregulatory properties of the novel mitochondria-targeted antioxidant SkQ1.
Yang Y; Karakhanova S; Soltek S; Werner J; Philippov PP; Bazhin AV
Mol Immunol; 2012 Aug; 52(1):19-29. PubMed ID: 22591624
[TBL] [Abstract][Full Text] [Related]
13. An attempt to prevent senescence: a mitochondrial approach.
Skulachev VP; Anisimov VN; Antonenko YN; Bakeeva LE; Chernyak BV; Erichev VP; Filenko OF; Kalinina NI; Kapelko VI; Kolosova NG; Kopnin BP; Korshunova GA; Lichinitser MR; Obukhova LA; Pasyukova EG; Pisarenko OI; Roginsky VA; Ruuge EK; Senin II; Severina II; Skulachev MV; Spivak IM; Tashlitsky VN; Tkachuk VA; Vyssokikh MY; Yaguzhinsky LS; Zorov DB
Biochim Biophys Acta; 2009 May; 1787(5):437-61. PubMed ID: 19159610
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis.
Andreev-Andrievskiy AA; Kolosova NG; Stefanova NA; Lovat MV; Egorov MV; Manskikh VN; Zinovkin RA; Galkin II; Prikhodko AS; Skulachev MV; Lukashev AN
Oxid Med Cell Longev; 2016; 2016():8703645. PubMed ID: 27293517
[TBL] [Abstract][Full Text] [Related]
15. 10-(6'-Plastoquinonyl)decyltriphenylphosphonium (SkQ1) Does Not Increase the Level of Cytochromes P450 in Rat Liver and Human Hepatocyte Cell Culture.
Myasoedova KN; Silachev DN; Petrov AD
Biochemistry (Mosc); 2016 Dec; 81(12):1488-1491. PubMed ID: 28259126
[TBL] [Abstract][Full Text] [Related]
16. Influence of 10-(6'-Plastoquinonyl)decyltriphenylphosphonium (SkQ1) on Oxidative Status in Rats with Protamine Sulfate-Induced Hyperglycemia.
Voronkova YG; Popova TN; Agarkov AA; Skulachev MV
Biochemistry (Mosc); 2015 Dec; 80(12):1606-13. PubMed ID: 26638686
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant mechanism of mitochondria-targeted plastoquinone SkQ1 is suppressed in aglycemic HepG2 cells dependent on oxidative phosphorylation.
Ježek J; Engstová H; Ježek P
Biochim Biophys Acta Bioenerg; 2017 Sep; 1858(9):750-762. PubMed ID: 28554565
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
[TBL] [Abstract][Full Text] [Related]
19. The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation.
Weniger M; Reinelt L; Neumann J; Holdt L; Ilmer M; Renz B; Hartwig W; Werner J; Bazhin AV; D'Haese JG
Oxid Med Cell Longev; 2016; 2016():4650489. PubMed ID: 27274778
[TBL] [Abstract][Full Text] [Related]
20. The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer.
Bazhin AV; Yang Y; D'Haese JG; Werner J; Philippov PP; Karakhanova S
Int J Cancer; 2016 Jul; 139(1):130-9. PubMed ID: 26914404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
